Andreas E. Kremer

机构：University of Zurich, University Hospital Zurich · ORCID：0000-0002-9263-948X

发表论文 392 篇 · 总被引 10376 次 · h-index 53

代表论文

• Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 23)
• Prognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis (2025 · Journal of Hepatology · 被引 14)
• The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view (2026 · Nature Reviews Gastroenterology & Hepatology · 被引 3)
• Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity: a multicentre, prospective observational study (2025 · Hepatology · 被引 3)
• The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche (2025 · Proceedings of the National Academy of Sciences · 被引 3)
• Meta‐Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary Cholangitis (2026 · Alimentary Pharmacology & Therapeutics · 被引 2)